Aptose Biosciences Inc (NASDAQ:APTO)

4.41
Delayed Data
As of 3:59pm ET
 +0.015 / +0.34%
Today’s Change
3.92
Today|||52-Week Range
9.25
+0.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization75.0K116.2K86.0K88.0K
 
 
 
 
 
 
Operating ExpensesGross Income-75.0K-116.2K-86.0K-88.0K
 
 
 
 
 
General Expenses12.5M14.0M11.7M29.0M
 
 
 
 
 
Research And Development4.9M7.8M6.2M18.7M
 
 
 
 
 
Total Operating Expenses12.6M14.1M11.8M29.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.6M-14.1M-11.8M-29.1M
 
 
 
 
 
Interest Expense On Debt33.6K0.000.000.00
 
 
Other Expenses961.4K-49.8K97.0K-44.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.4M-14.1M-11.7M-28.9M
 
 
 
 
 
Net Income-11.4M-14.1M-11.7M-28.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.9M12.7M22.3M33.4M
 
 
 
 
 
Shares To Calculate EPS Diluted11.9M12.7M22.3M33.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.96-$1.10-$0.52-$0.86
 
 
 
 
 
EPS Diluted-$0.96-$1.10-$0.52-$0.86